Day 1: Public Policy Panel
A panel of scientists, advocates, and policy experts discussed overcoming the challenges of human embryonic stem cell research. The panel was moderated by R. Alta Charo, JD, Professor of Law and Bioethics at the University of Wisconsin at Madison, and included David A. Carmel, Vice President, Business Development, StemCyte, Inc.; Dr. Gearhart; Michael Manganiello, principal, Whyte Hirschboeck Dudek Government Affairs; Dr. Melton; William B. Neaves, PhD, president and CEO, Stowers Institute for Medical Research; and Susan L. Solomon, JD, CEO of the New York Stem Cell Foundation.
Day 2: Research Conference
The NYSCF Translational Stem Cell Research Conference was co-chaired by John Gearhart, PhD, Director, Stem Cell Program, Institute for Cell Engineering, Johns Hopkins Medicine; Douglas Melton, PhD, co-director of the Harvard Stem Cell Institute; and Paul Nurse, PhD, president of The Rockefeller University. Among the presenters was Kevin Eggan, PhD, assistant professor of molecular and cellular biology at Harvard University and NYSCF's scientific director. Dr. Melton gave the keynote speech. Sessions explored the impact human embryonic stem cell research is having on efforts to improve our understanding of somatic cell nuclear transplantation techniques as well as cancer, neurological disorders, heart disease and diabetes.